sarpogrelate has been researched along with Graft Occlusion, Vascular in 2 studies
sarpogrelate: structure given in first source
Graft Occlusion, Vascular: Obstruction of flow in biological or prosthetic vascular grafts.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We recently found that chronic administration of the selective 5-HT(2A) receptor antagonist sarpogrelate hydrochloride (SH) enhances the function of endothelium-derived nitric oxide (NO) in rabbit vein grafts." | 1.35 | Chronic treatment of hydroxytryptamine type 2a receptor antagonist sarpogrelate hydrochloride modulates the vasoreactivity of serotonin in experimental rabbit vein grafts. ( Itoh, T; Kajikuri, J; Kodama, A; Komori, K, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kodama, A | 1 |
| Komori, K | 1 |
| Kajikuri, J | 1 |
| Itoh, T | 1 |
| Sharma, SK | 1 |
| Del Rizzo, DF | 1 |
| Zahradka, P | 1 |
| Bhangu, SK | 1 |
| Werner, JP | 1 |
| Kumamoto, H | 1 |
| Takeda, N | 1 |
| Dhalla, NS | 1 |
2 other studies available for sarpogrelate and Graft Occlusion, Vascular
| Article | Year |
|---|---|
Chronic treatment of hydroxytryptamine type 2a receptor antagonist sarpogrelate hydrochloride modulates the vasoreactivity of serotonin in experimental rabbit vein grafts.
Topics: Animals; Benzamides; Carotid Artery, Common; Dose-Response Relationship, Drug; Endothelium, Vascular | 2009 |
Sarpogrelate inhibits serotonin-induced proliferation of porcine coronary artery smooth muscle cells: implications for long-term graft patency.
Topics: Animals; Cell Division; Cells, Cultured; Coronary Vessels; Graft Occlusion, Vascular; Muscle, Smooth | 2001 |